logo
Share SHARE
FONT-SIZE Plus   Neg

Lupin Launches Generic Tricor Tablets In US

Pharma major Lupin Ltd., said its subsidiary Lupin Pharmaceuticals Inc. had launched its Fenofibrate tablets in 48 mg and 145 mg strengths in the US, for which it had received final approval from the US FDA.

Lupin's Fenofibrate tablets are the AB rated generic equivalent of Abbott's Tricor tablets and are indicated for primary hypercholesterolemia or mixed dyslipidemia and severe hypertriglyceridemia.

Abbott's Tricor tables, 48 mg and 145 mg, had sales of $1.26 billion as per IMS Health, June 2012.

Commenting on the approval, Lupin Pharmaceuticals CEO and Group President Vinita Gupta said, "We are very happy to bring this product to market in the US. Patients can be assured that they are receiving the same high quality product they have been accustomed to a a more affordable price."

At the BSE, Lupin shares are currently trading at Rs.565.50, up 0.60 percent from the previous close.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
HP launched a new slim Chromebook 11 G5 with a touchscreen. It will hit the market in October. Dow Chemical Co. announced a series of actions to achieve synergy capture from the restructuring of its ownership of the Dow Corning Corporation. The collective actions will result in a reduction of approximately 2,500 positions globally, or approximately four percent of Dow's workforce. South Korea's Fair Trade Commission or FTC is investigating Apple over some matters related to the tech giant in that country, Reuters reported, citing the head of the anti-competition body. FTC Chairman Jeong Jae-chan talked about the investigation during a parliamentary hearing on Tuesday, but has not disclosed further details.
comments powered by Disqus
Follow RTT